ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 244 filers reported holding ALKERMES PLC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,534,136 | -13.8% | 54,771 | -3.7% | 0.00% | 0.0% |
| Q2 2023 | $1,780,000 | +163.8% | 56,869 | +137.6% | 0.00% | – |
| Q1 2023 | $674,812 | +4.9% | 23,938 | -2.7% | 0.00% | – |
| Q4 2022 | $643,164 | +19.5% | 24,614 | +2.2% | 0.00% | – |
| Q3 2022 | $538,000 | -72.4% | 24,092 | -71.2% | 0.00% | -100.0% |
| Q4 2021 | $1,949,000 | -26.1% | 83,794 | -2.0% | 0.00% | 0.0% |
| Q3 2021 | $2,637,000 | +52.7% | 85,492 | +21.4% | 0.00% | 0.0% |
| Q2 2021 | $1,727,000 | +32.4% | 70,437 | +0.9% | 0.00% | – |
| Q1 2021 | $1,304,000 | – | 69,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |